We are live on
!
Find out more
CC
Capital Counsel Portfolio holdings
AUM
$2.35B
1-Year Est. Return
21.34%
This Fund
S&P 500
This Quarter
Est. Return
-0.64%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$1.8B
AUM Growth
-$17.9M
(-0.99%)
Cap. Flow
+$10.4M
Cap. Flow
% of AUM
0.58%
Top 10 Holdings %
Top 10 Hldgs %
90.84%
Holding
54
New
2
Increased
15
Reduced
8
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$8.93M |
| 2 |
Arista Networks
ANET
|
+$2.33M |
| 3 |
CME Group
CME
|
+$1.18M |
| 4 |
Mettler-Toledo International
MTD
|
+$599K |
| 5 |
Home Depot
HD
|
+$423K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
+$1.73M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.44M |
| 3 |
Apple
AAPL
|
+$686K |
| 4 |
Idexx Laboratories
IDXX
|
+$363K |
| 5 |
Reading International Class A
RDI
|
+$300K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.24% |
| 2 | Healthcare | 22.71% |
| 3 | Financials | 19.37% |
| 4 | Consumer Staples | 11.26% |
| 5 | Communication Services | 10.36% |
Similar funds
HFM
ROIC
EC
SCA
G
MC
BAM
BJL
Capital Counsel's Q3 2023 Portfolio in Review
As of Q3 2023, Capital Counsel held 54 positions worth $1.8B, down 0.99% from $1.81B the previous quarter. Its ten largest holdings account for 91% of the portfolio.
Capital Counsel's Q3 2023 filing shows 2 new, 15 increased, 8 reduced and 2 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 834 shares worth $328K. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $1.73M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.
- Capital Counsel's largest Q3 2023 buy was Vanguard S&P 500 ETF: 834 shares worth $328K.
- Capital Counsel added most to Qualcomm in Q3 2023, an estimated $8.93M increase.
- Capital Counsel's biggest Q3 2023 reduction was Alphabet (Google) Class C, cutting an estimated $1.44M.
- Capital Counsel fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $1.73M.
- Capital Counsel's ten largest holdings make up 91% of its $1.8B portfolio in Q3 2023.
- Capital Counsel opened 2 new positions and closed 2 in Q3 2023.
- Capital Counsel's portfolio value fell 0.99% quarter-over-quarter to $1.8B.
Based on Capital Counsel's 13F filing for Q3 2023, filed 14 Nov 2023.